- Report
- January 2026
- 195 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- January 2026
- 190 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- April 2026
- 196 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- August 2025
- 522 Pages
Global
From €4431EUR$4,950USD£3,870GBP
- Report
- April 2025
- 120 Pages
Global
From €5326EUR$5,950USD£4,652GBP
- Report
- January 2026
- 196 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- August 2025
- 186 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- August 2025
- 180 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- April 2026
- 370 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 172 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 166 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 162 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- August 2025
- 188 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- January 2026
- 120 Pages
Global
From €4252EUR$4,750USD£3,714GBP
- Report
- May 2025
- 164 Pages
Global
From €4252EUR$4,750USD£3,714GBP

Pharmaceutical Services Outsourcing (PSO) is a rapidly growing market within the pharmaceutical manufacturing industry. It involves the transfer of certain activities, such as drug development, clinical trials, and manufacturing, from pharmaceutical companies to third-party service providers. This allows pharmaceutical companies to focus on their core competencies while outsourcing non-core activities to specialized service providers. PSO also helps pharmaceutical companies reduce costs, increase efficiency, and improve quality.
The PSO market is segmented into drug development, clinical trials, and manufacturing services. Drug development services include pre-clinical and clinical research, regulatory affairs, and drug safety. Clinical trials services include clinical trial management, data management, and biostatistics. Manufacturing services include active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging and labeling.
Notable companies in the PSO market include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more